PLAY PODCASTS
Episode 65 - Carcinogen Classifications
Episode 65

Episode 65 - Carcinogen Classifications

The Occupational Safety Leadership Podcast

July 3, 20238m 18s

Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Episode 65 explains how carcinogens are classified across major regulatory and scientific bodies, why classifications differ, and how safety leaders should interpret carcinogenicity information on Safety Data Sheets (SDSs). Dr. Ayers focuses on helping organizations understand what the classifications actually mean for workplace controls.

  ☣️ What Carcinogens Are

Carcinogens are substances capable of causing cancer through:

  • DNA damage

  • Chronic exposure effects

  • Disruption of cellular processes

Cancer may develop years or decades after exposure, making early recognition and control essential.

  🏷️ Major Carcinogen Classification Systems

Episode 65 breaks down the three systems safety leaders encounter most often:

  1. GHS (Globally Harmonized System) — SDS Classification

Appears directly on SDSs.

  • Category 1A — Known human carcinogens (strong human evidence)

  • Category 1B — Presumed human carcinogens (animal evidence)

  • Category 2 — Suspected human carcinogens (limited evidence)

Common SDS hazard statements include:

  • “May cause cancer.”

  • “Suspected of causing cancer.”

These statements correspond directly to the categories above.

  2. IARC (International Agency for Research on Cancer)

Used globally by scientists and regulators.

  • Group 1 — Carcinogenic to humans

  • Group 2A — Probably carcinogenic

  • Group 2B — Possibly carcinogenic

  • Group 3 — Not classifiable

  • Group 4 — Probably not carcinogenic (rare)

IARC classifications are based on strength of evidence, not exposure level.

  3. NTP (National Toxicology Program)

Used widely in U.S. regulatory and scientific communities.

  • Known to be a human carcinogen

  • Reasonably anticipated to be a human carcinogen

NTP focuses on hazard identification, not workplace exposure limits.

  🔍 Why Classifications Differ

Dr. Ayers explains that systems differ because they evaluate:

  • Different types of evidence

  • Different endpoints

  • Different exposure assumptions

  • Different scientific thresholds

A chemical may be:

  • IARC Group 1

  • GHS Category 1B

  • NTP “Reasonably Anticipated”

…all at the same time, without contradiction.

  🧭 Practical Examples from the Episode

The podcast uses real‑world examples to show how classifications guide decisions:

  • A solvent labeled “may cause cancer” requires reviewing ventilation, PPE, and substitution.

  • A chemical with strong animal evidence (GHS 1B) may still require strict controls even if human data is limited.

  • A mixture may contain carcinogens even if the product name doesn’t suggest it—SDS review is essential.

  🛡️ Why Carcinogens Require Special Controls

Carcinogens often require:

  • Engineering controls (local exhaust, closed systems)

  • Exposure monitoring

  • Substitution analysis

  • Strict housekeeping to prevent dust or vapor buildup

  • Medical surveillance (depending on the chemical)

PPE alone is not considered adequate primary protection.

  🧑‍🏫 Leadership Responsibilities

To manage carcinogens effectively, leaders must:

  • Review SDSs for carcinogenicity classifications

  • Understand differences between GHS, IARC, and NTP

  • Ensure workers understand the meaning of carcinogen warnings

  • Verify controls match exposure potential

  • Maintain transparent, non‑fear‑based communication

  • Avoid discriminatory practices—controls must protect everyone

The episode emphasizes that carcinogen management is about risk reduction, not panic.